Global Vaccine Alliance Gavi to Invest $40 Million to Secure Mass Production of Future Ebola Vaccine
The international vaccine development and distribution organization Gavi announced this week that it had committed $50 million to responding to the ongoing Ebola outbreak in the Democratic Republic of the Congo (DRC), $40 million of which would go to building up supply chains in preparation of mass production of an Ebola Bundibugyo vaccine.







































